PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

MedPlus Health Services Limited

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from MedPlus Health Services Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.

What stands out

  • Profit Cash Ratio: Over the last 3 years, every ₹100 of reported profit came with ₹271 of operating cash. Higher than 93% of Healthcare companies in India.
  • Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 4.4 times. Higher than 88% of Healthcare companies in India.

Where ₹100 of sales goes

₹95Operating costs₹1.8Interest₹3.2Net profit

Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

₹271

Over the last 3 years, every ₹100 of reported profit came with ₹271 of operating cash.

Higher than 93% of Healthcare companies in India.

Self-Funding Ratio

4.4×

Over the last 3 years its own operating cash covered its investment spending (capex) 4.4 times.

Higher than 88% of Healthcare companies in India.

Cash Locked Ratio

₹15

For every ₹100 of sales, ₹15 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹18 tied up three years earlier.

Less money tied up than 68% of Healthcare companies in India.

Growth quality

Steadiness Ratio

3/3 · 3/3

Sales and profit both grew in each of the last 3 years.

Steadier than 83% of Healthcare companies in India.

Growth Efficiency Ratio

₹7

Sales grew 51% in 3 years; of every extra ₹100 of sales, ₹7 became extra profit.

Lower than 75% of Healthcare companies in India.

Asset Productivity Ratio

+51% / +41%

In 3 years sales changed by +51% while total assets changed by +41%. Sales grew faster than assets.

Balance-sheet strength

Debt Due Cover Ratio

No debt due

No debt falls due within a year, according to the latest yearly balance sheet.

Cash Cushion Ratio

−12%

Debt, after subtracting cash, equals 12% of its market value (net debt).

Lower than 81% of Healthcare companies in India.

Tangible Assets Ratio

99%

Of every ₹100 the company owns, ₹99 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

More tangible than 58% of Healthcare companies in India.

Tangible Net Worth Ratio

98%

Of every ₹100 of net worth, ₹98 is tangible; the rest is goodwill and other intangibles, often from buying other companies.

More tangible than 56% of Healthcare companies in India.

Shareholders

Shareholder Slice Ratio

+1%

Share count rose 1% in 3 years, so each share's slice of the company became smaller.

Bigger rise in share count than 67% of Healthcare companies in India.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (14)

MedPlus Health Services Limited owes ₹0.50 for every ₹1 it owns. Net profit rose 46% in the year to Mar 2026, and grew 64% a year on average over 3 years.

Compared with Healthcare companies in India · latest annual results Mar 2026.

P/E ratio

33.9

Investors pay ₹33.9 for every ₹1 of MedPlus Health Services Limited's yearly profit, lower than 56% of Healthcare companies in India.

P/B ratio

3.62

The share price is 3.62 times MedPlus Health Services Limited's book value per share, lower than 64% of Healthcare companies in India.

Market cap

₹7,142 Cr

The total market value of all of MedPlus Health Services Limited's shares at today's price (share price × number of shares), larger than 57% of Healthcare companies in India. PosiCap size class: Mini Cap.

Net worth (book value)

₹1,975 Cr

What MedPlus Health Services Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).

Book value per share

₹164.49

Net worth divided by the number of shares. The share price of ₹594.70 is 3.6 times this, which is the P/B above.

Return on equity (ROE)

10.7%

MedPlus Health Services Limited earned 10.7% on its shareholders' money over the last year, lower than 64% of Healthcare companies in India.

Owes vs Owns

0.50×

MedPlus Health Services Limited owes ₹0.50 for every ₹1 it owns (low), higher than 84% of Healthcare companies in India.

Dividend yield

None

MedPlus Health Services Limited does not currently pay a dividend.

Revenue growth

+12%

Revenue rose 12% in the year to Mar 2026, and grew 15% a year on average over 3 years.

Profit growth

+46%

Net profit rose 46% in the year to Mar 2026, and grew 64% a year on average over 3 years.

Profit margin

3.2%

MedPlus Health Services Limited keeps ₹3 of every ₹100 of revenue as net profit.

Cash quality

2.3×

Cash from MedPlus Health Services Limited's business was 2.3× its reported profit in the year to Mar 2026 — its profit turned into cash.

Interest cover

2.8×

MedPlus Health Services Limited's operating profit covered its interest costs 2.8 times in the year to Mar 2026.

Cash vs debt

Net debt

MedPlus Health Services Limited had ₹832 Cr more debt than cash (net debt) at Mar 2026.

Questions

What is MedPlus Health Services Limited's P/E ratio?

Investors pay ₹33.9 for every ₹1 of MedPlus Health Services Limited's yearly profit, lower than 56% of Healthcare companies in India.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For MedPlus Health Services Limited: ₹7,142 Cr ÷ ₹1,975 Cr (31 Mar 2026) = 3.6.

What is MedPlus Health Services Limited's return on equity?

MedPlus Health Services Limited earned 10.7% on its shareholders' money over the last year, lower than 64% of Healthcare companies in India.

How much does MedPlus Health Services Limited owe compared with what it owns?

MedPlus Health Services Limited owes ₹0.50 for every ₹1 it owns (low), higher than 84% of Healthcare companies in India.

Does MedPlus Health Services Limited pay a dividend?

No. MedPlus Health Services Limited does not currently pay a dividend.

Is MedPlus Health Services Limited's revenue growing?

Revenue rose 12% in the year to Mar 2026, and grew 15% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.